NVS News Today: Novartis Bolsters U.S. Supply Chain Amid Potential Tariffs

Novartis, a leading pharmaceutical company, is taking strategic steps to safeguard its U.S. operations amidst potential tariffs under the current trade environment. The company has fortified its stockpiles to ensure supply until mid-2026 and is planning to localize production within two years. This strategic move is essential as Novartis aims to mitigate risks associated with potential trade policies and maintain its robust presence in the U.S. market.